Cervical Screening (Pap Smear Test) is currently the most effective screening method for cervical cancer. The entire procedure takes only a few minutes and is painless. Cervical cells mutate several years before cervical cancer develops. Therefore, lesions can be detected through Pap Smear Test, and detailed examination or treatment can be arranged early to prevent the formation of cervical cancer. It is recommended that women who have had sexual experience or over the age of 25 should receive regular examinations. Regular examinations can prevent more than 90% of cervical cancer.

Cervical cancer is a common malignant tumor for women. The morbidity and mortality have been rising in recent years, with a notable trend of rejuvenation. Cervical cancer is also the only cancer with an evident cause and can be eliminated through early intervention. Developed by New Horizon Health, CerviClear is the first Urine-based HPV Detection and Cervical Cancer Screening Test in the world. It is the only product comprehensively covering all 14 high-risk HPV viruses (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) and achieves non-invasive home-based urine self-sampling. The product has already obtained a CE Mark, and is qualified to be launched in Hong Kong and the Greater Bay Area.

HPV DNA test identifies infection with specific HPV genotypes before changes occur in the cells of the cervix. Early detection of HPV infection and high-risk HPV types can effectively prevent cervical cancer. Cervical cancer is a grave threat to women’s health, ranking seventh most fatal cancer among women in Hong Kong. In 2017, 150 women died from the disease, accounting for 2.6% of all female cancer deaths. In recent years, the prevalence of cervical cancer among young women has been increasing, with a cervical cancer patient diagnosed at the age of 19. It is evident that cervical cancer is still a threat to women today and should not be ignored.

This is the latest human papillomavirus vaccine available on the market, effectively preventing cervical cancer, vulvar cancer, vaginal cancer, anal cancer, and genital warts (cauliflower warts).

Pneumococcus has over 100 serotypes, with serotype 3 being particularly threatening. Most severe cases of pneumonia and hospitalizations in both children and adults are caused by serotype 3 pneumococcus.

Key Information:

• 15-Valent Pneumococcal Vaccine:
  • Approved by the FDA and the European Union.
  • Widely used in countries such as the USA, UK, Canada, and Australia.
• Coverage: Protects against 15 serotypes of pneumococcus (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F).
• Preventable Diseases: Helps prevent pneumonia and invasive diseases, such as meningitis and septicemia.
• Eligibility: Suitable for infants aged 6 weeks and older.

Vaccination is essential for reducing the risk of serious pneumococcal infections.

MENACTRA

The pathogenic bacteria for epidemic meningitis is Neisseria meningitidis. Most invasive infections are caused by groups A, B, C, X, W135, and Y.

The pathogenic bacteria for epidemic meningitis is Neisseria meningitidis. Most invasive infections are caused by groups A, B, C, X, W135, and Y.

The incidence of epidemic meningitis caused by Neisseria meningitidis is much higher in countries such as the UK, the US, and Australia compared to Hong Kong. In Hong Kong, there are approximately 10-20 confirmed cases of this deadly infectious disease each year.

Shingles, commonly known as herpes zoster, is a disease caused by the varicella-zoster virus. Patients develop painful, band-like red rashes with blisters. Anyone who has had chickenpox has a chance of developing shingles.

Targeting more pneumococcal serotypes, including serotype 3, helps combat the globally prevalent pneumococcus and can induce lasting immune memory.

Suitable for individuals aged 50 and above, especially those at high risk such as those with diabetes, cardiovascular disease, or chronic lung disease, effectively preventing lower respiratory tract diseases caused by respiratory syncytial virus (RSV).